ATF7-NPFF

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, ATF7-NPFF Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ATF7-NPFF data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ATF7-NPFF Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated ATF7-NPFF expression acts as an unfavorable survival marker.

UCEC are the cancer types where ATF7-NPFF Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECDFSMedianII,III,IV0.1770.739<.00136view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ATF7-NPFF–UCEC (DFS)

Kaplan–Meier survival curve for ATF7-NPFF mutant vs wild-type samples in UCEC.

Open the UCEC breakdown →

Exploration